Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report

Rituximab pharmacokinetics in children and adolescents withde novointermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report

(2013) Matthew J. Barth et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report

(2013) Paul J. Galardy et al.   BRITISH JOURNAL OF HAEMATOLOGY

High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program

(2013) T. Intermesoli et al.   HAEMATOLOGICA

Low-Intensity Therapy in Adults with Burkitt's Lymphoma

(2013) Kieron Dunleavy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

(2012) Mitchell S. Cairo et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report

(2012) S Goldman et al.   LEUKEMIA

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis

(2011) J. A. Barnes et al.   ANNALS OF ONCOLOGY

RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B-cell lymphoma

(2011) Gaetano Corazzelli et al.   BRITISH JOURNAL OF HAEMATOLOGY

Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia

(2010) Andrea Meinhardt et al.   JOURNAL OF CLINICAL ONCOLOGY

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study

(2008) H A Poirel et al.   LEUKEMIA